Dysesthesias < Dyskinesia < Dyskinesia, drug‐induced

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]

Ident.	Authors (with country if any)	Title
003124 (2000)	Monica A. Beran-Koehn [États-Unis] ; Mary L. Zupanc [États-Unis] ; Marc C. Patterson [États-Unis] ; Douglas G. Olk [États-Unis] ; J. Eric Ahlskog [États-Unis]	Violent recurrent ballism associated with infections in two children with static encephalopathy
003292 (2000)	Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Lucy M. Blasucci [États-Unis]	Differential progression of motor impairment in levodopa‐treated Parkinson's disease
003372 (1999)	Franck Durif [France] ; Marie Vidailhet [France] ; Bérangère Debilly [France] ; Yves Agid [France]	Worsening of levodopa‐induced dyskinesias by motor and mental tasks
003427 (1999)	Pierre R. Burkhard [États-Unis] ; Heidi Shale [États-Unis] ; J. William Langston [États-Unis] ; James W. Tetrud [États-Unis]	Quantification of dyskinesia in Parkinson's disease: Validation of a novel instrumental method
003514 (1999)	Katrina A. Reardon [Australie] ; Mark Shiff [Australie] ; Peter A. Kempster [Australie]	Evolution of motor fluctuations in Parkinson's disease: A longitudinal study over 6 years
003628 (1998)	Nadir Syed [États-Unis] ; John Murphy [États-Unis] ; Thomas Zimmerman Jr. [États-Unis] ; Margery H. Mark [États-Unis] ; Jacob I. Sage [États-Unis]	Ten years' experience with enteral levodopa infusions for motor fluctuations in Parkinson's disease
003769 (1998)	Ronald K. B. Pearce [Royaume-Uni] ; Tara Banerji [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. David Marsden [Royaume-Uni]	De novo administration of ropinirole and bromocriptine induces less dyskinesia than L‐dopa in the MPTP‐treated marmoset
003777 (1998)	Marcelo Merello [Argentine] ; Angel Cammarota [Argentine] ; Maria I. Nouzeilles [Argentine] ; Osvaldo Betti [Argentine] ; Ram N Leiguarda [Argentine]	Confirmation of the antidyskinetic effect of posteroventral pallidotomy by means of an intraoperative apomorphine test
003815 (1998)	Pierre J. Blanchet [États-Unis] ; Spyridon Konitsiotis [États-Unis] ; Thomas N. Chase [États-Unis]	Amantadine reduces levodopa‐induced dyskinesias in parkinsonian monkeys
003819 (1998)	Brotchie [Royaume-Uni]	Adjuncts to dopamine replacement: A pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease
003915 (1997)	Bhatia [Royaume-Uni] ; Valerie L. Soland [Royaume-Uni] ; Mohit H. Bhatt [Inde] ; Niall P. Quinn [Royaume-Uni] ; C. David Marsden [Royaume-Uni]	Paroxysmal exercise‐induced dystonia: Eight new sporadic cases and a review of the literature
003B17 (1996)	Haw ; Thomas R. E. Barnes [Royaume-Uni] ; Kate Clark ; Paul Crichton [Royaume-Uni] ; Dora Kohen [Royaume-Uni]	Movement Disorder in Down's syndrome: A possible marker of the severity of mental handicap
003E02 (1994)	Goetz [États-Unis] ; G. T. Stebbins [États-Unis] ; H. M. Shale [États-Unis] ; A. E. Lang [Canada] ; D. A. Chernik [États-Unis] ; T. A. Chmura [États-Unis] ; J. E. Ahlskog [États-Unis] ; E. E. Dorflinger [États-Unis]	Utility of an objective dyskinesia rating scale for Parkinson's disease: Inter‐ and intrarater reliability assessment
003E12 (1994)	Trugman [États-Unis] ; Robert Leadbetter [États-Unis] ; Michael E. Zalis [États-Unis] ; Rose O. Burgdorf [États-Unis] ; G. Frederick Wooten [États-Unis]	Treatment of severe axial tardive dystonia with clozapine: Case report and hypothesis
003E28 (1994)	James P. Bennett Jr. [États-Unis] ; Elke R. Landow Jr. [États-Unis] ; Susan Dietrich [États-Unis] ; Lori A. Schuh [États-Unis]	Suppression of dyskinesias in advanced Parkinson's disease: Moderate daily clozapine doses provide long‐term dyskinesia reduction
003F26 (1994)	Kyllerman [Suède] ; O. H. Skjeldal [Norvège] ; M. Lundberg [Suède] ; I. Holme [Suède] ; E. Jellum [Norvège] ; U. Von Döbeln [Suède] ; A. Fossen [Norvège] ; G. Carlsson [Suède]	Dystonia and dyskinesia in glutaric aciduria type I: Clinical heterogeneity and therapeutic considerations
003F75 (1993)	Daniele Bravi [États-Unis] ; Thomas L. Davis [États-Unis] ; M. Maral Mouradian [États-Unis] ; Chase [États-Unis]	Treatment of parkinson's disease with the partial dopamine agonist EMD 49980
004015 (1993)	Harrison [États-Unis] ; G. R. Lyons [États-Unis] ; E. R. Landow [États-Unis]	Phenytoin and dyskinesias: A report of two cases and review of the literature
004024 (1993)	Robert A. Hauser [États-Unis] ; Olanow [États-Unis]	Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with parkinson's disease
004068 (1993)	Nutt [États-Unis] ; Julie H. Carter [États-Unis] ; William Woodward [États-Unis] ; John P. Hammerstad [États-Unis] ; Stephen T. Gancher [États-Unis]	Does tolerance develop to levodopa? Comparison of 2‐and 21‐h levodopa infusions
004237 (1992)	Factor [États-Unis] ; Diane Brown [États-Unis]	Clozapine prevents recurrence of psychosis in Parkinson's disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/KwdEn.i -k "Dyskinesia" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/KwdEn.i  \
                -Sk "Dyskinesia" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dyskinesia
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024